These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2859720)

  • 1. [Current trends in the development of vaccines].
    Zwisler O
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):165-74. PubMed ID: 2859720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharides and membrane vaccines.
    Poolman JT
    Adv Biotechnol Processes; 1990; 13():57-86. PubMed ID: 1970737
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New technology of vaccine production--international prospect of the development. Synthetic peptide vaccines and protein engineering].
    Aimoto S; Sakiyama F
    Nihon Rinsho; 1987 Oct; 45(10):2349-54. PubMed ID: 3502349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second generation meningococcal OMP-LPS vaccines.
    Poolman JT; van der Ley PA; Wiertz EJ; Hoogerhout P
    NIPH Ann; 1991 Dec; 14(2):233-41. PubMed ID: 1725922
    [No Abstract]   [Full Text] [Related]  

  • 7. [The new generations of vaccines against parasites].
    Wedrychowicz H
    Wiad Parazytol; 2000; 46(1):21-7. PubMed ID: 16886350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of antigenic specificity and design of new vaccines.
    Arnon R; Van Regenmortel MH
    FASEB J; 1992 Nov; 6(14):3265-74. PubMed ID: 1385242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal vaccines.
    Bethell D; Pollard AJ
    Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to vaccine development: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(3):479-84. PubMed ID: 3876169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends in the developments of bacterial vaccines.
    Lindberg AA; Pillai S
    Dev Biol Stand; 1996; 87():59-71. PubMed ID: 8854003
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiparasitic vaccines: where are we now?].
    Rogier C; Moukoko CE; Orlandi-Pradines E; Briolant S
    Rev Prat; 2007 Jan; 57(2):183-8. PubMed ID: 17432523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential of synthetic peptides for vaccines.
    Steward MW; Howard CR
    Med Lab Sci; 1985 Oct; 42(4):376-87. PubMed ID: 2417087
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant DNA technology for the preparation of subunit vaccines.
    Bachrach HL
    J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.